UW researchers found potential new treatments for a rare pediatric brain cancer each year that has a median survival time of ...
The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).
News-Medical.Net on MSN
UVA researcher wins $700,000 for promising ovarian cancer research
Promising ovarian cancer research by Melanie Rutkowski, PhD, at the University of Virginia Comprehensive Cancer Center has ...
Google DeepMind’s AI, specifically the Gemma model, has played a pivotal role in discovering a new potential pathway for cancer therapy. This breakthrough, which reveals a method to make tumors more ...
Calcipotriol plus 5-FU immunotherapy activates Th2 immunity, releasing IL-24 cytokines to suppress skin cancer development in patients with actinic keratosis. The combination therapy significantly ...
News Medical on MSN
UH pharmacology professor wins $900,000 grant to develop a dual-function nanodrug for cancer
Accelerating advancements in cancer prevention and cures, Wei Gao, assistant professor of pharmacology at the University of Houston College of Pharmacy, has received a $900,000 grant from the Cancer ...
Gastric cancer cells can activate KRAS-driven signals, enabling autonomous tumor growth by producing their own WNT proteins. New research reveals how gastric cancer cells exploit WNT signaling for ...
Over the years our annual Pathways to Health Symposium has hosted researchers and community champions to discuss important topics related to cancer health disparities. The Symposium provides a forum ...
Techno-Science.net on MSN
Effective diabetes medications to fight cancer
Could diabetes medications have an influence beyond simply regulating blood sugar? This question is gaining ground in ...
Members of the Senate Finance Committee have reintroduced the Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act, a bipartisan bill that would establish a Medicare Coverage pathway to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results